Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
13
×
Tags
boston blog main
13
×
life sciences
national blog main
boston top stories
national top stories
new york blog main
san diego blog main
san francisco blog main
biotech
clinical trials
new york top stories
san diego top stories
san francisco top stories
fda
indiana blog main
raleigh-durham blog main
seattle blog main
boston
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana top stories
national
raleigh-durham top stories
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
cancer
medicare
novartis
pfizer
alnylam pharmaceuticals
amgen
gene therapy
investing
What
patients
13
×
drug
fda
bio
medicine
roundup
healthcare
help
market
therapy
ago
alnylam
approved
developers
digital
disease
friday
gene
life
million
moves
new
pfizer
science
sets
startup
acorda
acquisitions
advantages
akcea
albert
amyloidosis
analytics
approve
aren’t
attr
available
awaits
award
bar
Language
unset
unknown
Current search:
" boston blog main "
×
photo
×
patients
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Digital Tools, Online Community & More: Patient Partnership Award Finalists
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets